These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2643917)

  • 21. Pure thalamic dementia with a single focus of spongiform change in cerebral cortex.
    Kornfeld M; Seelinger DF
    Clin Neuropathol; 1994; 13(2):77-81. PubMed ID: 8205730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
    Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement factors C1q and C3b in brains with Creutzfeldt-Jakob disease.
    Nawrocka-Kunecka A; Papierz W; Liberski PP
    Pol J Pathol; 2005; 56(3):127-9. PubMed ID: 16334980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nestin immunoreactivity of Purkinje cells in Creutzfeldt-Jakob disease.
    Mizuno Y; Ohama E; Hirato J; Nakazato Y; Takahashi H; Takatama M; Takeuchi T; Okamoto K
    J Neurol Sci; 2006 Jul; 246(1-2):131-7. PubMed ID: 16616189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
    Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
    Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.
    Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A
    Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelinated axon undergoes complete demyelination in the panencephalopathic--but it is merely subjected to the Wallerian degeneration in the polioencephalopathic type of transmissible spongiform encephalopathies.
    Liberski PP; Gajdusek DC
    Pol J Pathol; 1997; 48(3):163-71. PubMed ID: 9401409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease.
    Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular redistribution of components correlates with neuronal vulnerability.
    Adori C; Kovács GG; Low P; Molnár K; Gorbea C; Fellinger E; Budka H; Mayer RJ; László L
    Neurobiol Dis; 2005 Aug; 19(3):427-35. PubMed ID: 16023585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thalamic form of Creutzfeldt-Jakob disease].
    Heye N; Stoltenburg-Didinger G; Glasner H; Cervós-Novarro J
    Nervenarzt; 1993 Feb; 64(2):136-9. PubMed ID: 8450896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
    Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
    Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
    Tabaton M; Monaco S; Cordone MP; Colucci M; Giaccone G; Tagliavini F; Zanusso G
    Ann Neurol; 2004 Feb; 55(2):294-6. PubMed ID: 14755736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prionic neuroinvasion and cerebellar lesion in Creutzfeldt-Jakob disease].
    Karmysheva VIa; Pogodina VV
    Arkh Patol; 2006; 68(4):27-32. PubMed ID: 16986493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Panencephalopathy of the Creutzfeldt-Jakob disease type].
    Gertz HJ; Stoltenburg G; Cruz-Sanchez F; Lafuente J; Schopol R
    Nervenarzt; 1988 Feb; 59(2):110-2. PubMed ID: 3283576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal degeneration in experimental Creutzfeldt-Jakob disease.
    Hogan RN; Kingsbury DT; Baringer JR; Prusiner SB
    Lab Invest; 1983 Dec; 49(6):708-15. PubMed ID: 6361375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of the hippocampus in Creutzfeldt-Jakob disease.
    Masullo C; Macchi G
    Clin Neuropathol; 1997; 16(1):37-44. PubMed ID: 9020394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reevaluation of the ultrastructural pathology of experimental Creutzfeldt-Jakob disease. Serial studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in mice.
    Liberski PP; Yanagihara R; Asher DM; Gibbs CJ; Gajdusek DC
    Brain; 1990 Feb; 113 ( Pt 1)():121-37. PubMed ID: 2405952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.